Literature DB >> 7826013

Human papillomaviruses.

H zur Hausen1, E M de Villiers.   

Abstract

During the past 17 years 73 genotypes of human pathogenic papillomaviruses (HPV) have been identified. Most of them are found in benign proliferations; however, several have been discovered in malignant tumors. Specifically, cancer of the cervix, other anogenital cancers, but also some cancers of the skin, the oral and nasal cavity, and the rare periungual carcinomas have been linked to specific HPV infections. The pathogenesis of cancer of the cervix has been particularly well studied. Specific viral genes (E6 and E7) of high risk HPVs (types 16, 18, and others) act as oncogenes. Their expression emerges as necessary but not sufficient factors for malignant conversion. Besides stimulating cell proliferation, they are responsible for the genetic instability of the infected cells. Their transcriptional and functional activity is regulated by host cell genes. Mutational modifications of the latter appear to be required for malignant progression.

Entities:  

Mesh:

Year:  1994        PMID: 7826013     DOI: 10.1146/annurev.mi.48.100194.002235

Source DB:  PubMed          Journal:  Annu Rev Microbiol        ISSN: 0066-4227            Impact factor:   15.500


  122 in total

1.  Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.

Authors:  M Nees; J M Geoghegan; T Hyman; S Frank; L Miller; C D Woodworth
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  DNA-induced structural changes in the papillomavirus capsid.

Authors:  C Fligge; F Schäfer; H C Selinka; C Sapp; M Sapp
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation.

Authors:  Frauke Fehrmann; David J Klumpp; Laimonis A Laimins
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

4.  Both conserved region 1 (CR1) and CR2 of the human papillomavirus type 16 E7 oncogene are required for induction of epidermal hyperplasia and tumor formation in transgenic mice.

Authors:  G A Gulliver; R L Herber; A Liem; P F Lambert
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

5.  Differential deletions of chromosome 3p are associated with the development of uterine cervical carcinoma in Indian patients.

Authors:  S Dasgupta; S B Chakraborty; A Roy; S Roychowdhury; C K Panda
Journal:  Mol Pathol       Date:  2003-10

6.  The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification.

Authors:  Frank A Suprynowicz; Ewa Krawczyk; Jess D Hebert; Sawali R Sudarshan; Vera Simic; Christopher M Kamonjoh; Richard Schlegel
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

7.  Detection of HPV types and neutralizing antibodies in women with genital warts in Tianjin City, China.

Authors:  Xue-ling Wu; Chun-tao Zhang; Xiao-ke Zhu; You-chun Wang
Journal:  Virol Sin       Date:  2010-02-12       Impact factor: 4.327

8.  Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced disease.

Authors:  Jon D Reuter; Beatriz E Vivas-Gonzalez; Daniel Gomez; Jean H Wilson; Janet L Brandsma; Heather L Greenstone; John K Rose; Anjeanette Roberts
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Long-term effect of interferon on keratinocytes that maintain human papillomavirus type 31.

Authors:  Yijan E Chang; Loren Pena; Ganes C Sen; Jung K Park; Laimonis A Laimins
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Role of human papillomavirus in the pathogenesis of oral squamous cell carcinoma.

Authors:  Anastasios K Markopoulos
Journal:  World J Exp Med       Date:  2012-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.